Showing 1761-1770 of 2723 results for "".
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- FDA Clears Renuvion APR Handpiece for Coagulation of Subcutaneous Soft Tissues after Liposuction for Body Contouringhttps://modernaesthetics.com/news/fda-clears-renuvion-apr-handpiece-for-coagulation-of-subcutaneous-soft-tissues-after-liposuction-for-body-contouring/2473404/The U.S. Food and Drug Administration (FDA) cleared the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring. “The Renuvion APR handpiece is the only device to have a 510(k)
- Dr. Arthur Swift is Advanced Medaesthetic Partners’s New CMOhttps://modernaesthetics.com/news/dr-arthur-swift-is-advanced-medaesthetic-partnerss-new-cmo/2473400/Canadian plastic surgeon Arthur Swift, MD, is Advanced Medaesthetic Partners’s new Chief Medical Officer (CMO). “Dr. Swift brings a wealth of knowledge and experience that will be a key asset for our organization,” says Nicole Chiaramonte, AMP CEO, in a news
- Dr. Melinda Haws Named New Aesthetic Society Presidenthttps://modernaesthetics.com/news/dr-melinda-haws-named-new-aesthetic-society-president/2473398/Nashville, Tenn.-based plastic surgeon Melinda Haws, MD is the new president of the Aesthetic Society and the s
- Allergan Aesthetics Supports Women Surgeons with LIMITLESShttps://modernaesthetics.com/news/allergan-aesthetics-supports-women-surgeons-with-limitless/2473394/Allergan Aesthetics is launching LIMITLESS, an ongoing initiative in partnership with American Society of Plastic Surgeons (ASPS), The Aesthetic Society and the American Hernia Society. LIMITLESS was developed three years ago as a program to highlight women's achievements in p
- Plastic Surgeons Among Top Earners in 2022https://modernaesthetics.com/news/plastic-surgeons-among-top-earners-in-2023/2473393/The highest paid specialties in 2022 included plastic surgery ($619,000), orthopedics ($573,000), cardiology ($507,000) and urology ($506,000), according to the 2023 Medscape Physician Compensation Report. Dermatologists made about $443,000 in 2022. T